SiriusPoint agrees to sell ArmadaCare to Ambac for $250 million, anticipating a pre-tax gain of $220-230 million.
Quiver AI Summary
SiriusPoint Ltd. has announced the sale of its wholly owned supplemental health insurance program manager, ArmadaCare, to Ambac Financial Group Inc. for $250 million, with the transaction expected to close in the fourth quarter pending regulatory approvals. Post-sale, SiriusPoint anticipates a pre-tax gain of $220-230 million, valuing Armada at approximately 14 times its EBITDA, and expects a 10% increase in its pro-forma tangible book value. CEO Scott Egan highlighted the sale as a step to unlock off-balance sheet value and reaffirmed the company's commitment to its Accident & Health business, including its ownership of the travel platform International Medical Group. Jefferies LLC acted as the exclusive financial advisor, while Paul Hastings LLP served as legal advisor for the sale.
Potential Positives
- SiriusPoint is set to recognize a significant pre-tax gain of $220-230 million from the sale of ArmadaCare, strengthening its financial position.
- The transaction is expected to increase SiriusPoint's pro-forma tangible book value by approximately 10% upon completion.
- SiriusPoint maintains a continued partnership with Armada through a capacity agreement until the end of 2030, ensuring ongoing collaboration and revenue potential.
- The sale helps unlock off-balance sheet value for SiriusPoint, reflecting strategic financial management and focus on core business areas.
Potential Negatives
- Sale of ArmadaCare may indicate a strategic shift or divestiture that could be perceived as a loss of focus on key operational areas within the Accident & Health segment.
- Dependence on a long-term capacity partnership with Armada after the sale could raise concerns about the sustainability of SiriusPoint's business model in that segment.
- Uncertainty surrounding regulatory approvals and closing conditions could delay the expected financial benefits from the transaction.
FAQ
What recent agreement was announced by SiriusPoint?
SiriusPoint announced its agreement to sell ArmadaCare to Ambac Financial Group for $250 million.
How much pre-tax gain will SiriusPoint recognize from the sale?
SiriusPoint will recognize a pre-tax gain of $220-230 million from the sale of ArmadaCare.
What is the expected impact of the sale on SiriusPoint's tangible book value?
The pro-forma tangible book value is expected to increase by approximately 10% upon the close of the transaction.
When is the transaction expected to close?
The transaction is expected to close in the fourth quarter of 2025, pending regulatory approvals.
Who advised SiriusPoint on the sale of ArmadaCare?
Jefferies LLC served as SiriusPoint’s exclusive financial advisor, and Paul Hastings LLP was the legal advisor for the sale.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$SPNT Insider Trading Activity
$SPNT insiders have traded $SPNT stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $SPNT stock by insiders over the last 6 months:
- LA GUERONNIERE RAFE DE sold 30,000 shares for an estimated $586,500
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$SPNT Hedge Fund Activity
We have seen 116 institutional investors add shares of $SPNT stock to their portfolio, and 99 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL RESEARCH GLOBAL INVESTORS removed 1,200,000 shares (-17.4%) from their portfolio in Q2 2025, for an estimated $24,468,000
- GOLDMAN SACHS GROUP INC removed 1,102,751 shares (-52.8%) from their portfolio in Q2 2025, for an estimated $22,485,092
- AMERICAN CENTURY COMPANIES INC added 1,101,899 shares (+29.1%) to their portfolio in Q2 2025, for an estimated $22,467,720
- BLACKROCK, INC. added 976,349 shares (+9.4%) to their portfolio in Q2 2025, for an estimated $19,907,756
- DONALD SMITH & CO., INC. removed 923,472 shares (-11.9%) from their portfolio in Q2 2025, for an estimated $18,829,594
- PRIVATE MANAGEMENT GROUP INC removed 864,487 shares (-19.7%) from their portfolio in Q2 2025, for an estimated $17,626,889
- VICTORY CAPITAL MANAGEMENT INC added 834,708 shares (+30.4%) to their portfolio in Q2 2025, for an estimated $17,019,696
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$SPNT Analyst Ratings
Wall Street analysts have issued reports on $SPNT in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- B. Riley Securities issued a "Buy" rating on 07/21/2025
- Oppenheimer issued a "Outperform" rating on 06/26/2025
To track analyst ratings and price targets for $SPNT, check out Quiver Quantitative's $SPNT forecast page.
$SPNT Price Targets
Multiple analysts have issued price targets for $SPNT recently. We have seen 3 analysts offer price targets for $SPNT in the last 6 months, with a median target of $25.0.
Here are some recent targets:
- Randy Binner from B. Riley Securities set a target price of $30.0 on 07/21/2025
- Michael Phillips from Oppenheimer set a target price of $25.0 on 06/26/2025
- Andrew Andersen from Jefferies set a target price of $17.0 on 04/15/2025
Full Release
HAMILTON, Bermuda, Sept. 29, 2025 (GLOBE NEWSWIRE) -- SiriusPoint Ltd. (“SiriusPoint”) (NYSE: SPNT), a global specialty insurer and reinsurer, has today announced its agreement to sell wholly owned supplemental health insurance program manager, ArmadaCare (“Armada”) to Ambac Financial Group Inc. (“Ambac”) for $250 million. SiriusPoint will continue its capacity partnership with Armada until the end of 2030.
Upon completion of the sale, SiriusPoint will recognize a pre-tax gain of $220-230 million, with the transaction valuing Armada at approximately 14x EBITDA 1 . Pro-forma tangible book value is expected to increase by approximately 10% upon close.
Scott Egan, SiriusPoint’s Chief Executive Officer, said: “The sale of our equity stake is an important step in unlocking the significant off-balance sheet value of Armada. We look forward to continuing our strong partnership with the team through our long-term capacity agreement.
“We are proud of our leading capabilities in the Accident & Health segment, which includes our ownership of premier travel platform International Medical Group (IMG), and we see attractive growth opportunities for our A&H business going forward.
“We reaffirm our across-the-cycle target return on equity of 12% to 15%.”
The transaction is expected to close in the fourth quarter, subject to customary closing conditions and receipt of regulatory approvals.
Jefferies LLC served as SiriusPoint’s exclusive financial advisor and Paul Hastings LLP served as legal advisor in the sale of Armada.
About SiriusPoint
SiriusPoint is a global underwriter of insurance and reinsurance providing solutions to clients and brokers around the world. Bermuda-headquartered with offices in New York, London, Stockholm and other locations, we are listed on the New York Stock Exchange (SPNT). We have licenses to write Property & Casualty and Accident & Health insurance and reinsurance globally. Our offering and distribution capabilities are strengthened by a portfolio of strategic partnerships with Managing General Agents and Program Administrators. With approximately $2.8 billion total capital, SiriusPoint’s operating companies have a financial strength rating of A- (Excellent) from AM Best, S&P and Fitch, and A3 from Moody’s. For more information, please visit
https://www.siriuspt.com/
About ArmadaCare
A leading insurance program manager, ArmadaCare delivers uncommon health insurance solutions designed to enhance ordinary health benefits. With the steadfast belief that health insurance should be better, ArmadaCare’s plans fill voids in coverage for routine and unexpected healthcare expenses, offer valuable health and productivity support services and invite usage with modern conveniences and people-first service. The result gives our clients the edge they need to retain, recruit and reward key talent. Learn more at
www.ArmadaCare.com
About Ambac
Ambac Financial Group, Inc. (“Ambac” or “AFG”) is an insurance holding company headquartered in New York City. Ambac consists of a diverse mix of specialty insurance underwriting and distribution businesses in the U.S. and U.K. Ambac’s common stock trades on the New York Stock Exchange under the symbol “AMBC”. For more information, please go to
www.ambac.com
Forward-Looking Statements
We make statements in this press release that are forward-looking statements within the meaning of the U.S. federal securities laws. We intend these forward-looking statements to be covered by the safe harbor provisions for forward-looking statements in the U.S. Federal securities laws. These statements involve risks and uncertainties that could cause actual results to differ materially from those contained in the forward-looking statements. These risks and uncertainties include, but are not limited to, the impact of general economic conditions and conditions affecting the insurance and reinsurance industry; the adequacy of our reserves; fluctuation in the results of operations; pandemic or other catastrophic event; uncertainty of success in investing in early-stage companies, such as the risk of loss of an initial investment, highly variable returns on investments, delay in receiving return on investment and difficulty in liquidating the investment; our ability to assess underwriting risk, trends in rates for property and casualty insurance and reinsurance, competition, investment market and investment income fluctuations; trends in insured and paid losses; regulatory and legal uncertainties; and other risk factors described in SiriusPoint’s Annual Report on Form 10-K for the period ended December 31, 2024. Except as required by applicable law or regulation, we disclaim any obligation to publicly update or revise any forward-looking statement to reflect changes in underlying assumptions or factors, or new information, data or methods, future events or other circumstances after the date of this press release.
Contacts
Investor Relations
Liam Blackledge, SiriusPoint
[email protected]
+44 203 772 3082
Media
Sarah Hills, Rein4ce
[email protected]
+44 7718 882011
1 Based on Last Twelve Months Adjusted Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA).